{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T17:11:17Z","timestamp":1780074677525,"version":"3.54.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina de Familia. SEMERGEN"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.semerg.2020.06.024","type":"journal-article","created":{"date-parts":[[2020,8,7]],"date-time":"2020-08-07T17:31:33Z","timestamp":1596821493000},"page":"81-90","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Adherencia terap\u00e9utica a f\u00e1rmacos biol\u00f3gicos en pacientes con artritis reumatoide, artritis psori\u00e1sica y espondilitis anquilosante. (Estudio ADhER-1)"],"prefix":"10.1016","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6730-1957","authenticated-orcid":false,"given":"J.","family":"N\u00fa\u00f1ez-Rodr\u00edguez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7452-2205","authenticated-orcid":false,"given":"Y.","family":"Gonz\u00e1lez-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.J.","family":"Nebot-Villacampa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Zafra-Morales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.C.","family":"Obaldia-Ala\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Caso-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semerg.2020.06.024_bib0165","doi-asserted-by":"crossref","first-page":"e015872","DOI":"10.1136\/bmjopen-2017-015872","article-title":"Adherence and dosing interval of subcutaneous antitumour necrosis factor biologics among patients with inflammatory arthritis: analysis from a Canadian administrative database","volume":"7","author":"Bhoi","year":"2017","journal-title":"BMJ Open."},{"key":"10.1016\/j.semerg.2020.06.024_bib0170","unstructured":"Sociedad Espa\u00f1ola de Farmacia Hospitalaria. Lo que debes saber sobre la adherencia al tratamiento. Badalona: Euromedice Vivactis; 2017. [consultada 27 Ene 2020]. Disponible en: https:\/\/www.sefh.es\/bibliotecavirtual\/Adherencia2017\/libro_ADHERENCIA.pdf"},{"key":"10.1016\/j.semerg.2020.06.024_bib0175","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.semarthrit.2017.03.010","article-title":"Medication adherence and persistence over time with self-administered TNF-alpha inhibitors among young adult, middle-aged, and older patients with rheumatologic conditions","volume":"47","author":"Calip","year":"2017","journal-title":"Semin Arthritis Rheum."},{"key":"10.1016\/j.semerg.2020.06.024_bib0180","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/ddr.20484","article-title":"Predictors of medication adherence in patients with rheumatoid arthritis","volume":"72","author":"Salt","year":"2011","journal-title":"Drug Dev Res."},{"key":"10.1016\/j.semerg.2020.06.024_bib0185","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3390\/medicina56040178","article-title":"The influence of socio-demographic factors lifestyle and psychiatric indicators on adherence to treatment of patients with rheumatoid arthritis: A Cross-Sectional Study","volume":"56","author":"Turcu-Stiolica","year":"2020","journal-title":"Medicina"},{"key":"10.1016\/j.semerg.2020.06.024_bib0190","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1007\/s00296-017-3758-6","article-title":"Adherence of rheumatoid arthritis patients to biologic disease-modifying antirheumatic drugs: a cross-sectional study","volume":"37","author":"Mena-Vazquez","year":"2017","journal-title":"Rheumatol Int."},{"key":"10.1016\/j.semerg.2020.06.024_bib0195","first-page":"134","article-title":"Adherencia a las terapias biol\u00f3gicas en pacientes con artropat\u00edas inflamatorias cr\u00f3nicas","volume":"43","author":"Mart\u00ednez-L\u00f3pez de Castro","year":"2019","journal-title":"Farm Hosp."},{"key":"10.1016\/j.semerg.2020.06.024_bib0200","doi-asserted-by":"crossref","first-page":"e000585","DOI":"10.1136\/rmdopen-2017-000585","article-title":"Predicting adherence to therapy in rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis: a large cross-sectional study","volume":"5","author":"Smolen","year":"2019","journal-title":"RMD Open."},{"key":"10.1016\/j.semerg.2020.06.024_bib0205","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1007\/s10067-013-2221-7","article-title":"Adherence to treatment in patients with ankylosing spondylitis","volume":"32","author":"Arturi","year":"2013","journal-title":"Clin Rheumatol."},{"issue":"3.","key":"10.1016\/j.semerg.2020.06.024_bib0210","article-title":"Primary nonadherence associated clinical outcomes, and health care resource use among patients with rheumatoid arthritis prescribed treatment with injectable biologic disease-modifying antirheumatic drugs","volume":"22","author":"Harnett","year":"2016","journal-title":"J Manag Care Spec Pharm."},{"key":"10.1016\/j.semerg.2020.06.024_bib0215","first-page":"63","article-title":"The role of the general practitioner in the monitoring and follow-up of patients treated with Sarilumab","volume":"14","author":"Tejedor","year":"2018","journal-title":"Reumatol Clin Supl."},{"key":"10.1016\/j.semerg.2020.06.024_bib0220","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"Arnett","year":"1987","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.semerg.2020.06.024_bib0225","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1002\/art.21972","article-title":"Classification criteria for psoriatic arthritis: development of new criteria from a large international study","volume":"54","author":"Taylor","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.semerg.2020.06.024_bib0230","first-page":"908","article-title":"The outcome of ankylosing spondylitis: A study of 100 patients","volume":"24","author":"Gran","year":"1997","journal-title":"Br J Rheumatology."},{"key":"10.1016\/j.semerg.2020.06.024_bib0235","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/art.1780270401","article-title":"Evaluation of\u00a0diagnostic criteria for ankylosing spondylitis: a proposal for the modification of the New York criteria","volume":"27","author":"Van der Linden","year":"1984","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.semerg.2020.06.024_bib0240","first-page":"2116","article-title":"Spanish version of the Health Assessment Questionnaire: reliability, validity and transcultural equivalency Grupo para la Adaptaci\u00f3n del HAQ a la Poblaci\u00f3n Espa\u00f1ola","volume":"20","author":"Esteve-Vives","year":"1993","journal-title":"J Rheumatol."},{"key":"10.1016\/j.semerg.2020.06.024_bib0245","first-page":"579","article-title":"Development of a disease activity score based on judgment in clinical practice by rheumatologists","volume":"20","author":"Van der Heijde","year":"1993","journal-title":"J Rheumatol."},{"key":"10.1016\/j.semerg.2020.06.024_bib0250","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1136\/ard.2009.122259","article-title":"Application of the DAREA\/DAPSA score for assessment of disease activity in psoriatic arthritis","volume":"69","author":"Schoels","year":"2010","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.semerg.2020.06.024_bib0255","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/ard.2008.094870","article-title":"Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis","volume":"68","author":"Lukas","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semerg.2020.06.024_bib0260","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1177\/1060028016656385","article-title":"Cross-cultural Adaptation and Validation of the Medication Regimen Complexity Index Adapted to Spanish","volume":"50","author":"Saez de la Fuente","year":"2016","journal-title":"Ann Pharmacother."},{"key":"10.1016\/j.semerg.2020.06.024_bib0265","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1093\/ajhp\/52.21.2415","article-title":"Cost of medication- related problems at a university hospital","volume":"52","author":"Schneider","year":"1995","journal-title":"Am J Health Syst Pharm."},{"key":"10.1016\/j.semerg.2020.06.024_bib0270","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.clinthera.2011.06.001","article-title":"Measurement and rates of persistence with and adherence to biologics for rheumatoid arthritis: a systematic review","volume":"33","author":"Blum","year":"2011","journal-title":"Clin Ther"},{"key":"10.1016\/j.semerg.2020.06.024_bib0275","first-page":"2469","article-title":"The compliance-questionnaire-rheumatology compared with electronic medication event monitoring: a validation study","volume":"30","author":"De Klerk","year":"2003","journal-title":"J Rheumatol."},{"key":"10.1016\/j.semerg.2020.06.024_bib0280","doi-asserted-by":"crossref","first-page":"e62775","DOI":"10.1371\/journal.pone.0062775","article-title":"Determinants of medication adherence to antihypertensive medications among a Chinese population using Morisky Medication Adherence Scale","volume":"8","author":"Lee","year":"2013","journal-title":"PLoS One."},{"key":"10.1016\/j.semerg.2020.06.024_bib0285","first-page":"330","article-title":"The Helsinki Declaration regarding ethics in clinical research","volume":"83","author":"Wilde","year":"2000","journal-title":"J Med Assoc Thai."},{"key":"10.1016\/j.semerg.2020.06.024_bib0290","unstructured":"Espa\u00f1a. Ley Org\u00e1nica 3\/2018, de 5 de Dic, de Protecci\u00f3n de Datos Personales y garant\u00eda de los derechos digitales. BOE, 6 de diciembre de 2018, n\u00fam. 294. [consultada 13 Mar d 2020]. Disponible en: https:\/\/www.boe.es\/boe\/dias\/2018\/12\/06\/pdfs\/BOE-A-2018-16673.pdf.."},{"key":"10.1016\/j.semerg.2020.06.024_bib0295","first-page":"423","article-title":"Non-adherence to subcutaneous biological medication in patients with rheumatoid arthritis: a multicentre, non-interventional study","volume":"35","author":"Calvo-Al\u00e9n","year":"2017","journal-title":"Clin Exp Rheumatol."},{"key":"10.1016\/j.semerg.2020.06.024_bib0300","doi-asserted-by":"crossref","first-page":"A650","DOI":"10.1016\/j.jval.2015.09.2336","article-title":"Association of medication persistency with route of administration and patient cost-sharing: analysis of commonly used biologics","volume":"18","author":"Shim","year":"2015","journal-title":"Value Health."},{"key":"10.1016\/j.semerg.2020.06.024_bib0305","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1007\/s12325-015-0256-7","article-title":"A systematic review of factors associated with non-adherence to treatment for immune-mediated inflammatory diseases","volume":"32","author":"Vangeli","year":"2015","journal-title":"Adv Ther."},{"key":"10.1016\/j.semerg.2020.06.024_bib0310","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1007\/s00228-017-2315-2","article-title":"Association between medication regimen complexity and pharmacotherapy adherence: a systematic review","volume":"73","author":"Pantuzza","year":"2017","journal-title":"Eur J Clin Pharmacol."},{"key":"10.1016\/j.semerg.2020.06.024_bib0315","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.rce.2018.04.009","article-title":"Complejidad del r\u00e9gimen de medicaci\u00f3n en pacientes pluripatol\u00f3gicos","volume":"218","author":"Mu\u00f1oz","year":"2018","journal-title":"Rev Clin Esp."},{"key":"10.1016\/j.semerg.2020.06.024_bib0320","series-title":"Orphan lung diseases: a clinical guide to rare lung disease.","first-page":"1","article-title":"Orphan lung diseases from definition to organization of care","author":"Cordier","year":"2015"}],"container-title":["Medicina de Familia. SEMERGEN"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1138359320302501?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1138359320302501?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T04:40:35Z","timestamp":1761108035000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1138359320302501"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S1138359320302501"],"URL":"https:\/\/doi.org\/10.1016\/j.semerg.2020.06.024","relation":{},"ISSN":["1138-3593"],"issn-type":[{"value":"1138-3593","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adherencia terap\u00e9utica a f\u00e1rmacos biol\u00f3gicos en pacientes con artritis reumatoide, artritis psori\u00e1sica y espondilitis anquilosante. (Estudio ADhER-1)","name":"articletitle","label":"Article Title"},{"value":"Medicina de Familia. SEMERGEN","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semerg.2020.06.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Sociedad Espa\u00f1ola de M\u00e9dicos de Atenci\u00f3n Primaria (SEMERGEN). Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}